The rare disease company

Search for more information about CENTOGENE and its dedicated team of professionals. Find details of our accreditation, commitment to social responsibility and our collaboration partners. Discover the latest news, conferences and events we are attending, plus all our current career opportunities.

  1. About Us

Dedicated to improving the lives of patients every day

CENTOGENE is a worldwide leader in the field of genetic diagnostics for rare hereditary diseases - with the largest test portfolio worldwide. Testing samples from over 100 different countries allows CENTOGENE a unique insight into the epidemiological basis of hereditary disorders, which is crucial for interpreting results and transform it into medical reports.

The company firmly focuses on offering quality molecular genetic diagnostics, underlined by its multiple international accreditations (CAP, CLIA, ISO). Our in-depth medical expertise is supported by the application of cutting-edge technologies, including next generation sequencing, whole genome sequencing (CentoGenome®), whole exome sequencing (CentoXome®) and innovative biomarkers for selected diseases. CENTOGENE has developed a comprehensive mutation database (CentoMD®) that is pivotal to offering high-quality diagnostic reporting and medical interpretation; thoroughly interpreting each patient’s sequence data.

In addition to diagnostic services for individual patients, CENTOGENE is also a pivotal partner for numerous high-profile industrial companies worldwide.

CENTOGENE cares – Our social responsibility

Nowadays, companies realize more than ever the need to take a social responsibility and to give something back the society.

CENTOGENE recognizes its social obligation and is undertaking active and sustainable steps to make the world a better place. As a global leader in the field of clinical genetic diagnostics and interpretation of rare diseases, the health of the people lies in the middle of our hearts.

Read more

Meet our experts at upcoming conferences


Meet our experts in San Diego, USA.


Meet our experts at the ACMG Clinical Genetics Meeting from 21st to 25th March 2017 in Phoenix, Arizona.


Meet our experts at the ESHG from 27th to 30th May 2017 in Copenhagen, Denmark.


Meet our experts in October 2017.

Become part of our team and start your career at CENTOGENE

Join our young and growing company - an international and innovative work environment awaits you in one of the world´s leading companies for rare hereditary diseases diagnostics.

SHOW VACANCIES AT CENTOGENE

Our business locations – Where to find us

CENTOGENE AG is one of the world's leading companies in the field of rare genetic disease diagnostics.

With our broad international network of experienced employees, we are able to offer a wide range of services and support in diverse local languages worldwide.

In collaboration with our partners, we continually develop and test new diagnostic techniques, and are therefore always able to offer you the latest and most effective solutions to your diagnostic challenges.

Rostock Headquarter

CENTOGENE AG
Schillingallee 68
18057 Rostock
Germany

Dubai Business Location

CENTOGENE FZ-LLC
Executive office No. 32 Floor 8
Aurora Tower, Dubai Media City
P.O.Box 500717
Dubai, U.A.E 

Vienna Business Location

CENTOGENE GmbH
Mariahilfer Str. 36
1070 Vienna
Austria

Berlin Business Location

CENTOGENE AG
Zimmerstr. 69
10117 Berlin
Germany

India Business Location

CENTOGENE India Private Limited
107 Wegman's Business Park, Knowledge Park III,
Surajpur-Kasna Road, Greater NOIDA - 201308,
Uttar Pradesh
India

CENTOGENE has recently added numerous single gene tests and next generation sequencing (NGS) panels to its portfolio. Our NGS panel compositions always reflect...

Read more

Dr. Arndt Rolfs, CEO CENTOGENE, presented at JP Morgan Healthcare Conference 2017 about CENTOGENE's self-amplifying business model - diagnostics, proprietary...

Read more

For the first time, ever, the Parkinson’s Institute and Clinical Center and CENTOGENE have entered into a collaboration aimed at genetic screening of a large...

Read more

Arndt Rolfs, CEO and founder of CENTOGENE, will present the company’s business model on Wednesday, January 11, 2017, at 4:30 pm PST.

Read more

CENTOGENE announces today a new sequencing facility for rare hereditary disorders, which will use Illumina’s HiSeq X® sequencer.

Read more

The “Deutschlandstipendium” is a scholarship that helps support gifted and talented students enrolled at German universities that are public institutions or are...

Read more

CENTOGENE is proud to contribute to the Face2Gene 60 Day Challenge. This initiative by FDNA was started November 1, 2016.

Read more

CENTOGENE successfully became part of the Illumina Propel Certification Program for Core and Service Labs.

Read more

CENTOEGENE AG (CENTOGENE) and Interactive Biosoftware (IBS) announce to start their collaboration on the integration of CENTOGENE’s unique genomic database...

Read more